APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Narcotics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Opioid Narcotics Market Analysis and Forecast 2026-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchOpioid Narcotics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Narcotics Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Opioid Narcotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Narcotics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Narcotics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Opioid Narcotics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Opioid Narcotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Opioid Narcotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Opioid Narcotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Opioid Narcotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Opioid Narcotics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Narcotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Opioid Narcotics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Opioid Narcotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Opioid Narcotics sales, projected growth trends, production technology, application and end-user industry.

Opioid Narcotics Segment by Company

Yichang Renfu Pharmaceutical Co., Ltd.

Jiangsu Enhua Pharmaceutical Co., Ltd.

Henan Lingrui Pharmaceutical Co., Ltd.

Sinopharm Group Industrial Co., Ltd. Langfang Branch

Changzhou Siyao Pharmaceutical Co., Ltd.

Reig Jofre

Pfizer

GSK

Fresenius Kabi

Daiichi Sankyo

AcelRx Pharmaceuticals, Inc

Abbott

Opioid Narcotics Segment by Type

Fentanyl

Remifentanil

Sufentanil

Opioid Narcotics Segment by Application

Hospital

Clinic

Other

Opioid Narcotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Opioid Narcotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Narcotics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Opioid Narcotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fentanyl Major Manufacturers Table 3. Remifentanil Major Manufacturers Table 4. Sufentanil Major Manufacturers Table 5. Global Opioid Narcotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Opioid Narcotics Industry Trends Table 10. Opioid Narcotics Industry Drivers Table 11. Opioid Narcotics Industry Opportunities and Challenges Table 12. Opioid Narcotics Industry Restraints Table 13. Global Opioid Narcotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Opioid Narcotics Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Opioid Narcotics Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Opioid Narcotics Revenue Market Share by Region (2021-2026) Table 17. Global Opioid Narcotics Revenue Market Share by Region (2027-2032) Table 18. Global Opioid Narcotics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Opioid Narcotics Sales by Region (2021-2026) & (K Units) Table 20. Global Opioid Narcotics Sales by Region (2027-2032) & (K Units) Table 21. Global Opioid Narcotics Sales Market Share by Region (2021-2026) Table 22. Global Opioid Narcotics Sales Market Share by Region (2027-2032) Table 23. Global Opioid Narcotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Opioid Narcotics Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Opioid Narcotics Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Opioid Narcotics Sales Market Share by Manufacturers (2021-2026) Table 27. Global Opioid Narcotics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Opioid Narcotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Opioid Narcotics Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Opioid Narcotics Manufacturers, Product Type & Application Table 31. Global Opioid Narcotics Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Opioid Narcotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Opioid Narcotics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Opioid Narcotics Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Opioid Narcotics Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Opioid Narcotics Revenue Market Share by Type (2021-2026) Table 38. Global Opioid Narcotics Revenue Market Share by Type (2027-2032) Table 39. Global Opioid Narcotics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 41. Global Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 42. Global Opioid Narcotics Sales Market Share by Type (2021-2026) Table 43. Global Opioid Narcotics Sales Market Share by Type (2027-2032) Table 44. Global Opioid Narcotics Price by Type (2021-2026) & (US$/Unit) Table 45. Global Opioid Narcotics Price by Type (2027-2032) & (US$/Unit) Table 46. Global Opioid Narcotics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Opioid Narcotics Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Opioid Narcotics Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Opioid Narcotics Revenue Market Share by Application (2021-2026) Table 50. Global Opioid Narcotics Revenue Market Share by Application (2027-2032) Table 51. Global Opioid Narcotics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 53. Global Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 54. Global Opioid Narcotics Sales Market Share by Application (2021-2026) Table 55. Global Opioid Narcotics Sales Market Share by Application (2027-2032) Table 56. Global Opioid Narcotics Price by Application (2021-2026) & (US$/Unit) Table 57. Global Opioid Narcotics Price by Application (2027-2032) & (US$/Unit) Table 58. Yichang Renfu Pharmaceutical Co., Ltd. Company Information Table 59. Yichang Renfu Pharmaceutical Co., Ltd. Business Overview Table 60. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 62. Yichang Renfu Pharmaceutical Co., Ltd. Recent Development Table 63. Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information Table 64. Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview Table 65. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 67. Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Development Table 68. Henan Lingrui Pharmaceutical Co., Ltd. Company Information Table 69. Henan Lingrui Pharmaceutical Co., Ltd. Business Overview Table 70. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 72. Henan Lingrui Pharmaceutical Co., Ltd. Recent Development Table 73. Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information Table 74. Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview Table 75. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio Table 77. Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Development Table 78. Changzhou Siyao Pharmaceutical Co., Ltd. Company Information Table 79. Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview Table 80. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 82. Changzhou Siyao Pharmaceutical Co., Ltd. Recent Development Table 83. Reig Jofre Company Information Table 84. Reig Jofre Business Overview Table 85. Reig Jofre Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Reig Jofre Opioid Narcotics Product Portfolio Table 87. Reig Jofre Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pfizer Opioid Narcotics Product Portfolio Table 92. Pfizer Recent Development Table 93. GSK Company Information Table 94. GSK Business Overview Table 95. GSK Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. GSK Opioid Narcotics Product Portfolio Table 97. GSK Recent Development Table 98. Fresenius Kabi Company Information Table 99. Fresenius Kabi Business Overview Table 100. Fresenius Kabi Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Fresenius Kabi Opioid Narcotics Product Portfolio Table 102. Fresenius Kabi Recent Development Table 103. Daiichi Sankyo Company Information Table 104. Daiichi Sankyo Business Overview Table 105. Daiichi Sankyo Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Daiichi Sankyo Opioid Narcotics Product Portfolio Table 107. Daiichi Sankyo Recent Development Table 108. AcelRx Pharmaceuticals, Inc Company Information Table 109. AcelRx Pharmaceuticals, Inc Business Overview Table 110. AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio Table 112. AcelRx Pharmaceuticals, Inc Recent Development Table 113. Abbott Company Information Table 114. Abbott Business Overview Table 115. Abbott Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Abbott Opioid Narcotics Product Portfolio Table 117. Abbott Recent Development Table 118. North America Opioid Narcotics Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Opioid Narcotics Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 121. North America Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 122. North America Opioid Narcotics Sales Price by Type (2021-2026) & (US$/Unit) Table 123. North America Opioid Narcotics Sales Price by Type (2027-2032) & (US$/Unit) Table 124. North America Opioid Narcotics Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Opioid Narcotics Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 127. North America Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 128. North America Opioid Narcotics Sales Price by Application (2021-2026) & (US$/Unit) Table 129. North America Opioid Narcotics Sales Price by Application (2027-2032) & (US$/Unit) Table 130. North America Opioid Narcotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Opioid Narcotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Opioid Narcotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Opioid Narcotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 134. North America Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 135. North America Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 136. North America Opioid Narcotics Sales Price by Country (2021-2026) & (US$/Unit) Table 137. North America Opioid Narcotics Sales Price by Country (2027-2032) & (US$/Unit) Table 138. United States Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 139. Canada Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 140. Mexico Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 141. Europe Opioid Narcotics Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Opioid Narcotics Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 144. Europe Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 145. Europe Opioid Narcotics Sales Price by Type (2021-2026) & (US$/Unit) Table 146. Europe Opioid Narcotics Sales Price by Type (2027-2032) & (US$/Unit) Table 147. Europe Opioid Narcotics Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Opioid Narcotics Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 150. Europe Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 151. Europe Opioid Narcotics Sales Price by Application (2021-2026) & (US$/Unit) Table 152. Europe Opioid Narcotics Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Europe Opioid Narcotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Opioid Narcotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Opioid Narcotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Opioid Narcotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 157. Europe Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 158. Europe Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 159. Europe Opioid Narcotics Sales Price by Country (2021-2026) & (US$/Unit) Table 160. Europe Opioid Narcotics Sales Price by Country (2027-2032) & (US$/Unit) Table 161. Germany Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 162. France Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 163. U.K. Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 164. Italy Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 165. Russia Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 166. Spain Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 168. Switzerland Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 169. Sweden Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 170. Poland Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 171. China Opioid Narcotics Revenue by Type (2021-2026) & (US$ Million) Table 172. China Opioid Narcotics Revenue by Type (2027-2032) & (US$ Million) Table 173. China Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 174. China Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 175. China Opioid Narcotics Sales Price by Type (2021-2026) & (US$/Unit) Table 176. China Opioid Narcotics Sales Price by Type (2027-2032) & (US$/Unit) Table 177. China Opioid Narcotics Revenue by Application (2021-2026) & (US$ Million) Table 178. China Opioid Narcotics Revenue by Application (2027-2032) & (US$ Million) Table 179. China Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 180. China Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 181. China Opioid Narcotics Sales Price by Application (2021-2026) & (US$/Unit) Table 182. China Opioid Narcotics Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Opioid Narcotics Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Opioid Narcotics Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 186. Asia Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 187. Asia Opioid Narcotics Sales Price by Type (2021-2026) & (US$/Unit) Table 188. Asia Opioid Narcotics Sales Price by Type (2027-2032) & (US$/Unit) Table 189. Asia Opioid Narcotics Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Opioid Narcotics Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 192. Asia Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 193. Asia Opioid Narcotics Sales Price by Application (2021-2026) & (US$/Unit) Table 194. Asia Opioid Narcotics Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia Opioid Narcotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Opioid Narcotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Opioid Narcotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Opioid Narcotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. Asia Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 200. Asia Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 201. Asia Opioid Narcotics Sales Price by Country (2021-2026) & (US$/Unit) Table 202. Asia Opioid Narcotics Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Japan Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 204. South Korea Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 205. India Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 206. Australia Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 207. Taiwan Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Opioid Narcotics Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Opioid Narcotics Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 212. SAMEA Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 213. SAMEA Opioid Narcotics Sales Price by Type (2021-2026) & (US$/Unit) Table 214. SAMEA Opioid Narcotics Sales Price by Type (2027-2032) & (US$/Unit) Table 215. SAMEA Opioid Narcotics Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Opioid Narcotics Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 218. SAMEA Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 219. SAMEA Opioid Narcotics Sales Price by Application (2021-2026) & (US$/Unit) Table 220. SAMEA Opioid Narcotics Sales Price by Application (2027-2032) & (US$/Unit) Table 221. SAMEA Opioid Narcotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Opioid Narcotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Opioid Narcotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Opioid Narcotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 225. SAMEA Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 226. SAMEA Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 227. SAMEA Opioid Narcotics Sales Price by Country (2021-2026) & (US$/Unit) Table 228. SAMEA Opioid Narcotics Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Brazil Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 230. Argentina Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 231. Chile Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 232. Colombia Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 233. Peru Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 235. Israel Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 236. UAE Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 237. Turkey Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 238. Iran Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 239. Egypt Opioid Narcotics Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Opioid Narcotics Distributors List Table 243. Opioid Narcotics Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Opioid Narcotics Image Figure 2. Global Opioid Narcotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Narcotics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fentanyl Image Figure 5. Remifentanil Image Figure 6. Sufentanil Image Figure 7. Global Opioid Narcotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Opioid Narcotics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Opioid Narcotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Opioid Narcotics Revenue (2021-2032) & (US$ Million) Figure 14. Global Opioid Narcotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Opioid Narcotics Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Opioid Narcotics Revenue Market Share by Region (2021-2032) Figure 17. Global Opioid Narcotics Sales (2021-2032) & (K Units) Figure 18. Global Opioid Narcotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Opioid Narcotics Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Opioid Narcotics Sales YoY (2021-2032) & (K Units) Figure 21. Europe Opioid Narcotics Sales YoY (2021-2032) & (K Units) Figure 22. China Opioid Narcotics Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Opioid Narcotics Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Opioid Narcotics Sales YoY (2021-2032) & (K Units) Figure 25. Global Opioid Narcotics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Opioid Narcotics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Opioid Narcotics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Opioid Narcotics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Opioid Narcotics Revenue Market Share by Type (2021-2032) Figure 31. Global Opioid Narcotics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Opioid Narcotics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Opioid Narcotics Sales Market Share by Type (2021-2032) Figure 34. Global Opioid Narcotics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Opioid Narcotics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Opioid Narcotics Revenue Market Share by Application (2021-2032) Figure 37. Global Opioid Narcotics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Opioid Narcotics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Opioid Narcotics Sales Market Share by Application (2021-2032) Figure 40. North America Opioid Narcotics Revenue Share by Type (2021-2032) Figure 41. North America Opioid Narcotics Sales Share by Type (2021-2032) Figure 42. North America Opioid Narcotics Revenue Share by Application (2021-2032) Figure 43. North America Opioid Narcotics Sales Share by Application (2021-2032) Figure 44. North America Opioid Narcotics Revenue Share by Country (2021-2032) Figure 45. North America Opioid Narcotics Sales Share by Country (2021-2032) Figure 46. Europe Opioid Narcotics Revenue Share by Type (2021-2032) Figure 47. Europe Opioid Narcotics Sales Share by Type (2021-2032) Figure 48. Europe Opioid Narcotics Revenue Share by Application (2021-2032) Figure 49. Europe Opioid Narcotics Sales Share by Application (2021-2032) Figure 50. Europe Opioid Narcotics Revenue Share by Country (2021-2032) Figure 51. Europe Opioid Narcotics Sales Share by Country (2021-2032) Figure 52. China Opioid Narcotics Revenue Share by Type (2021-2032) Figure 53. China Opioid Narcotics Sales Share by Type (2021-2032) Figure 54. China Opioid Narcotics Revenue Share by Application (2021-2032) Figure 55. China Opioid Narcotics Sales Share by Application (2021-2032) Figure 56. Asia Opioid Narcotics Revenue Share by Type (2021-2032) Figure 57. Asia Opioid Narcotics Sales Share by Type (2021-2032) Figure 58. Asia Opioid Narcotics Revenue Share by Application (2021-2032) Figure 59. Asia Opioid Narcotics Sales Share by Application (2021-2032) Figure 60. Asia Opioid Narcotics Revenue Share by Country (2021-2032) Figure 61. Asia Opioid Narcotics Sales Share by Country (2021-2032) Figure 62. SAMEA Opioid Narcotics Revenue Share by Type (2021-2032) Figure 63. SAMEA Opioid Narcotics Sales Share by Type (2021-2032) Figure 64. SAMEA Opioid Narcotics Revenue Share by Application (2021-2032) Figure 65. SAMEA Opioid Narcotics Sales Share by Application (2021-2032) Figure 66. SAMEA Opioid Narcotics Revenue Share by Country (2021-2032) Figure 67. SAMEA Opioid Narcotics Sales Share by Country (2021-2032) Figure 68. Opioid Narcotics Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Opioid Narcotics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl
  • Remifentanil
  • Sufentanil
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yichang Renfu Pharmaceutical Co., Ltd.
  • Jiangsu Enhua Pharmaceutical Co., Ltd.
  • Henan Lingrui Pharmaceutical Co., Ltd.
  • Sinopharm Group Industrial Co., Ltd. Langfang Branch
  • Changzhou Siyao Pharmaceutical Co., Ltd.
  • Reig Jofre
  • Pfizer
  • GSK
  • Fresenius Kabi
  • Daiichi Sankyo
  • AcelRx Pharmaceuticals, Inc
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Opioid Narcotics Market by Type
  3. 1.2.1 Global Opioid Narcotics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fentanyl
  5. 1.2.3 Remifentanil
  6. 1.2.4 Sufentanil
  7. 1.3 Opioid Narcotics Market by Application
  8. 1.3.1 Global Opioid Narcotics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Opioid Narcotics Market Dynamics
  1. 2.1 Opioid Narcotics Industry Trends
  2. 2.2 Opioid Narcotics Industry Drivers
  3. 2.3 Opioid Narcotics Industry Opportunities and Challenges
  4. 2.4 Opioid Narcotics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Opioid Narcotics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Opioid Narcotics Revenue by Region
  3. 3.2.1 Global Opioid Narcotics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Opioid Narcotics Revenue by Region (2021-2026)
  5. 3.2.3 Global Opioid Narcotics Revenue by Region (2027-2032)
  6. 3.2.4 Global Opioid Narcotics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Opioid Narcotics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Opioid Narcotics Sales by Region
  9. 3.4.1 Global Opioid Narcotics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Opioid Narcotics Sales by Region (2021-2026)
  11. 3.4.3 Global Opioid Narcotics Sales by Region (2027-2032)
  12. 3.4.4 Global Opioid Narcotics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Opioid Narcotics Revenue by Manufacturers
  2. 4.1.1 Global Opioid Narcotics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Opioid Narcotics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Opioid Narcotics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Opioid Narcotics Sales by Manufacturers
  6. 4.2.1 Global Opioid Narcotics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Opioid Narcotics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Opioid Narcotics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Opioid Narcotics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Opioid Narcotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Opioid Narcotics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Opioid Narcotics Manufacturers, Product Type & Application
  13. 4.7 Global Opioid Narcotics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Opioid Narcotics Market CR5 and HHI
  16. 4.8.2 2025 Opioid Narcotics Tier 1, Tier 2, and Tier 3
5 Opioid Narcotics Market by Type
  1. 5.1 Global Opioid Narcotics Revenue by Type
  2. 5.1.1 Global Opioid Narcotics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Opioid Narcotics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Opioid Narcotics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Opioid Narcotics Sales by Type
  6. 5.2.1 Global Opioid Narcotics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioid Narcotics Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Opioid Narcotics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Opioid Narcotics Price by Type
6 Opioid Narcotics Market by Application
  1. 6.1 Global Opioid Narcotics Revenue by Application
  2. 6.1.1 Global Opioid Narcotics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Opioid Narcotics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Opioid Narcotics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Opioid Narcotics Sales by Application
  6. 6.2.1 Global Opioid Narcotics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Opioid Narcotics Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Opioid Narcotics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Opioid Narcotics Price by Application
7 Company Profiles
  1. 7.1 Yichang Renfu Pharmaceutical Co., Ltd.
  2. 7.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  6. 7.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
  8. 7.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  12. 7.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Henan Lingrui Pharmaceutical Co., Ltd.
  14. 7.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  18. 7.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
  20. 7.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
  21. 7.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
  22. 7.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
  24. 7.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
  25. 7.5 Changzhou Siyao Pharmaceutical Co., Ltd.
  26. 7.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  30. 7.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Reig Jofre
  32. 7.6.1 Reig Jofre Company Information
  33. 7.6.2 Reig Jofre Business Overview
  34. 7.6.3 Reig Jofre Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Reig Jofre Opioid Narcotics Product Portfolio
  36. 7.6.5 Reig Jofre Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Opioid Narcotics Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 GSK
  44. 7.8.1 GSK Company Information
  45. 7.8.2 GSK Business Overview
  46. 7.8.3 GSK Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GSK Opioid Narcotics Product Portfolio
  48. 7.8.5 GSK Recent Developments
  49. 7.9 Fresenius Kabi
  50. 7.9.1 Fresenius Kabi Company Information
  51. 7.9.2 Fresenius Kabi Business Overview
  52. 7.9.3 Fresenius Kabi Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
  54. 7.9.5 Fresenius Kabi Recent Developments
  55. 7.10 Daiichi Sankyo
  56. 7.10.1 Daiichi Sankyo Company Information
  57. 7.10.2 Daiichi Sankyo Business Overview
  58. 7.10.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
  60. 7.10.5 Daiichi Sankyo Recent Developments
  61. 7.11 AcelRx Pharmaceuticals, Inc
  62. 7.11.1 AcelRx Pharmaceuticals, Inc Company Information
  63. 7.11.2 AcelRx Pharmaceuticals, Inc Business Overview
  64. 7.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
  66. 7.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
  67. 7.12 Abbott
  68. 7.12.1 Abbott Company Information
  69. 7.12.2 Abbott Business Overview
  70. 7.12.3 Abbott Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Abbott Opioid Narcotics Product Portfolio
  72. 7.12.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Opioid Narcotics Market Size by Type
  2. 8.1.1 North America Opioid Narcotics Revenue by Type (2021-2032)
  3. 8.1.2 North America Opioid Narcotics Sales by Type (2021-2032)
  4. 8.1.3 North America Opioid Narcotics Price by Type (2021-2032)
  5. 8.2 North America Opioid Narcotics Market Size by Application
  6. 8.2.1 North America Opioid Narcotics Revenue by Application (2021-2032)
  7. 8.2.2 North America Opioid Narcotics Sales by Application (2021-2032)
  8. 8.2.3 North America Opioid Narcotics Price by Application (2021-2032)
  9. 8.3 North America Opioid Narcotics Market Size by Country
  10. 8.3.1 North America Opioid Narcotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Opioid Narcotics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Opioid Narcotics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Opioid Narcotics Market Size by Type
  2. 9.1.1 Europe Opioid Narcotics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Opioid Narcotics Sales by Type (2021-2032)
  4. 9.1.3 Europe Opioid Narcotics Price by Type (2021-2032)
  5. 9.2 Europe Opioid Narcotics Market Size by Application
  6. 9.2.1 Europe Opioid Narcotics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Opioid Narcotics Sales by Application (2021-2032)
  8. 9.2.3 Europe Opioid Narcotics Price by Application (2021-2032)
  9. 9.3 Europe Opioid Narcotics Market Size by Country
  10. 9.3.1 Europe Opioid Narcotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Opioid Narcotics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Opioid Narcotics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Opioid Narcotics Market Size by Type
  2. 10.1.1 China Opioid Narcotics Revenue by Type (2021-2032)
  3. 10.1.2 China Opioid Narcotics Sales by Type (2021-2032)
  4. 10.1.3 China Opioid Narcotics Price by Type (2021-2032)
  5. 10.2 China Opioid Narcotics Market Size by Application
  6. 10.2.1 China Opioid Narcotics Revenue by Application (2021-2032)
  7. 10.2.2 China Opioid Narcotics Sales by Application (2021-2032)
  8. 10.2.3 China Opioid Narcotics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Opioid Narcotics Market Size by Type
  2. 11.1.1 Asia Opioid Narcotics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Opioid Narcotics Sales by Type (2021-2032)
  4. 11.1.3 Asia Opioid Narcotics Price by Type (2021-2032)
  5. 11.2 Asia Opioid Narcotics Market Size by Application
  6. 11.2.1 Asia Opioid Narcotics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Opioid Narcotics Sales by Application (2021-2032)
  8. 11.2.3 Asia Opioid Narcotics Price by Application (2021-2032)
  9. 11.3 Asia Opioid Narcotics Market Size by Country
  10. 11.3.1 Asia Opioid Narcotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Opioid Narcotics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Opioid Narcotics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Opioid Narcotics Market Size by Type
  2. 12.1.1 SAMEA Opioid Narcotics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Opioid Narcotics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Opioid Narcotics Price by Type (2021-2032)
  5. 12.2 SAMEA Opioid Narcotics Market Size by Application
  6. 12.2.1 SAMEA Opioid Narcotics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Opioid Narcotics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Opioid Narcotics Price by Application (2021-2032)
  9. 12.3 SAMEA Opioid Narcotics Market Size by Country
  10. 12.3.1 SAMEA Opioid Narcotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Opioid Narcotics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Opioid Narcotics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Opioid Narcotics Value Chain Analysis
  2. 13.1.1 Opioid Narcotics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Opioid Narcotics Production Mode & Process
  6. 13.2 Opioid Narcotics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Opioid Narcotics Distributors
  9. 13.2.3 Opioid Narcotics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst